![]() |
市場調查報告書
商品編碼
1466548
器官移植市場:按類型和最終用戶分類 - 全球預測 2024-2030Organ Transplantation Market by Type (Heart Transplantation, Kidney Transplantation, Liver Transplantation), End User (Hospitals & Care Providers, Transplant Centers) - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年器官移植市場規模為164.5億美元,預計2024年將達到180.7億美元,2030年將達到326.9億美元,複合年成長率為10.30%。
器官移植市場包括與人體器官的採購、分配和移植給需要器官替代治療的患者相關的所有活動。相關人員包括器官捐贈組織、移植中心、醫療機構、提供抗排斥藥物的製藥公司以及開發人造器官和輔助技術的生物醫學公司。最終用途包括用捐贈者的功能性器官替換有缺陷的器官的臨床程序、醫療追蹤以及移植前後的持續患者照護。器官移植市場的成長有幾個因素,包括器官移植手術數量的增加、慢性病盛行率的增加和器官衰竭案例的加速,以及器官捐贈者和合法化途徑的開拓。然而,一些限制和挑戰影響了器官移植的採用,包括器官捐贈者短缺、治療成本上升、器官排斥和移植後併發症的風險,以及對我所給予的器官移植的社會和倫理問題。同時,器官移植方法的技術進步、器官捐贈意識的提高、器官和組織3D生物列印的進步以及降低排斥和併發症風險的個人化免疫抑制通訊協定預計將在未來幾年繼續帶來潛在的商機。
主要市場統計 | |
---|---|
基準年[2023] | 164.5億美元 |
預測年份 [2024] | 180.7億美元 |
預測年份 [2030] | 326.9億美元 |
複合年成長率(%) | 10.30% |
由於腎臟病類型增加,腎臟移植數量迅速增加
心臟移植是在其他手術治療失敗時對末期心臟衰竭或嚴重冠狀動脈疾病患者進行的重要外科手術。由於供體心臟有限,心臟移植的需求通常超過供應。腎臟移植涉及用捐贈者的健康腎臟取代患病的腎臟。由於高血壓和糖尿病引起的腎臟疾病的盛行率不斷增加,這種類型的移植需求量很大。腎臟移植通常比其他器官移植更常見,因為腎臟來自活體捐贈者,這可以增加捐贈者庫。肝臟移植是移植捐贈者的全部或部分肝臟的手術。此手術主要適用於因肝硬化或丙型肝炎等疾病導致的末期肝病或急性肝功能衰竭的患者。肝臟移植市場包括免疫抑制藥物和涉及器官保存解決方案的生技公司。肺移植用捐贈者的健康肺部替換患病的肺。它通常用於患有嚴重、危及生命的肺部疾病的患者,例如慢性阻塞性肺病(COPD)、囊腫纖維化或肺纖維化。胰臟移植通常用於治療第 1 型糖尿病,並且經常與腎臟移植合併使用。這項手術可以消除糖尿病患者對胰島素治療的需求。
最終使用者:由於我們員工的專業知識和技能,移植中心的器官移植正在不斷發展。
醫院和護理人員在器官移植過程中發揮著至關重要的作用。他們是潛在接受者的第一個聯絡人,並促進治療診斷和移植後護理。他們的偏好包括確保器官活力的高品質和可靠的器官儲存和運輸系統、先進的手術設備以及用於複雜移植手術的手術室技術。移植中心是專門從事器官移植的專業機構。就人員和技術專長而言,它們往往是更先進的設施。移植中心使用最新的免疫抑制劑方案和治療方法,以及先進的組織配對技術,以根據您的需求更好地匹配捐贈者和接受者。
區域洞察
由於強大的醫療基礎設施、成熟的器官捐贈網路以及對研發的大量投資,美洲器官移植呈現快速成長。美國消費者對器官捐贈和器官移植的認知度較高,相關服務的需求也較高。南美洲的器官移植市場正在擴大,以巴西和阿根廷等國家為首。政府提高器官捐贈率和改善移植服務的措施正在推動市場發展。歐洲擁有強大的醫療基礎設施和全面的器官移植政策,西班牙等國家因其高效的捐贈者管理系統而受到認可。先進技術的引入和專業移植服務的可用性正在促進該市場的成長。由於醫療保健支出的增加和法律規範的不斷發展,中東器官移植市場出現成長。文化和宗教因素顯著影響消費行為。在非洲,基礎設施的挑戰和醫療保健的差異阻礙了器官移植。然而,在一些地區建立移植計畫的進展面臨資金、公眾意識和監管障礙等障礙。由於慢性病的增加、醫療保健支出的增加以及政府促進器官捐贈的努力,亞太地區的器官移植市場正在迅速開拓。由於對醫療基礎設施的大量投資和不斷壯大的中階,中國的器官移植事業正在迅速成長。日本擁有完善的醫療保健體系,但面臨人口老化和對器官捐贈的文化抵制等挑戰。印度是一個複雜的器官移植市場,在獲得醫療服務方面存在巨大差異。需求不斷增加,尤其是在都市區,私立醫院在移植服務方面處於主導。
FPNV定位矩陣
FPNV定位矩陣對於評估器官移植市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估,供應商被分為四個成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對器官移植市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該行業競爭特徵的寶貴見解,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略,從而在市場上獲得競爭優勢。
1. 市場滲透率:提供有關主要企業所服務的市場的全面資訊。
2. 市場開拓:我們深入研究利潤豐厚的新興市場,並分析其在成熟細分市場的滲透率。
3. 市場多元化:提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。
4. 競爭評估和情報:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況和製造能力進行全面評估。
5. 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。
1.器官移植市場的市場規模與預測是多少?
2.在器官移植市場的預測期間內,有哪些產品、細分市場、應用和領域需要考慮投資?
3.器官移植市場的技術趨勢和法規結構是什麼?
4.器官移植市場主要廠商的市場佔有率是多少?
5.進入器官移植市場的合適型態和策略手段是什麼?
[181 Pages Report] The Organ Transplantation Market size was estimated at USD 16.45 billion in 2023 and expected to reach USD 18.07 billion in 2024, at a CAGR 10.30% to reach USD 32.69 billion by 2030.
The organ transplantation market encompasses all activities related to procuring, distributing, and transplanting human organs to patients requiring organ replacement therapy. It includes stakeholders such as organ donation agencies, transplant centers, healthcare facilities, pharmaceutical companies that provide anti-rejection medications, and biomedical companies that create artificial organs and support technologies. Application and end-use involve clinical procedures for replacing a faulty organ with a functioning organ from a donor, medical follow-up, and ongoing patient care for pre-and post-transplant scenarios. Several factors contribute to the growth of the organ transplantation market, including an increasing number of organ transplantation surgeries, the increasing prevalence of chronic diseases and accelerating cases of organ failure, and the development of legalized channels for organ donors and transplants. However, several limitations and challenges impact the adoption of organ transplantation, such as shortage of organ donors and high cost of treatment, risk of organ rejection and post-transplant complications, and social and ethical concerns in organ transplantation. On the other hand, technological advancement in organ transplantation methods, increasing awareness of organ donation, advancements in 3D bioprinting of organs and tissues, and personalized immunosuppression protocols to reduce the risk of rejection and complications present potential opportunities for the organ transplantation market in the coming years.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 16.45 billion |
Estimated Year [2024] | USD 18.07 billion |
Forecast Year [2030] | USD 32.69 billion |
CAGR (%) | 10.30% |
Type: Burgeoning kidney transplantation due to the increasing incidence of kidney diseases
Heart transplantation is a critical surgical procedure performed on patients with end-stage heart failure or extreme coronary artery disease when other surgical treatments fail. The demand for heart transplants usually outweighs the supply due to the limited availability of donor hearts. Kidney transplantation involves replacing a diseased kidney with a healthy one from a donor. This type of transplant is in high demand owing to the increasing incidence of kidney diseases, often resulting from hypertension and diabetes. Kidney transplants are usually more common than other organ transplants because kidneys can be donated by living donors, increasing the donor pool. Liver transplantation is the surgical alteration of a diseased liver with a complete or partial liver from a donor. This procedure is primarily indicated for patients with end-stage liver disease or acute liver failure, often due to conditions such as cirrhosis or hepatitis C. The market for liver transplantation includes pharmaceuticals for immunosuppression, along with biotechnology companies engaged in organ preservation solutions. Lung transplantation replaces diseased lungs with healthy lungs from a donor. It is generally reserved for individuals suffering from severe, life-threatening lung conditions such as chronic obstructive pulmonary disease (COPD), cystic fibrosis, or pulmonary fibrosis. Pancreas transplantation is usually performed to treat type 1 diabetes, often in conjunction with kidney transplantation. This procedure can eliminate the need for insulin therapy for diabetic patients.
End User: Evolving organ transplantation in transplant centers owing to the specialization of staff and the technology
Hospitals and care providers play a pivotal role in the organ transplantation process. They are potential recipients' first point of contact and facilitate diagnosing treatment and post-transplant care. Their need-based preferences include high-quality, reliable organ preservation and transport systems to ensure organ viability, advanced surgical equipment, and operating room technology tailored for complex transplant operations. Transplant centers are specialized facilities that focus exclusively on organ transplants. They tend to be more advanced in terms of the specialization of staff and technology. Transplant centers' need-based preferences include the latest immunosuppressive drug protocols, treatments, and advanced tissue-typing technology to ensure better donor-recipient matches.
Regional Insights
The Americas represents a rapid growth in organ transplantation due to a robust healthcare infrastructure, established organ donation networks, and significant investments in research and development. Consumers in the US show high awareness regarding organ donation and transplantation, leading to substantial demand for related services. The organ transplantation market in South America is expanding, with countries such as Brazil and Argentina at the forefront. The markets are driven by governmental initiatives to increase organ donation rates and improve transplantation services. Europe exhibits a robust healthcare infrastructure and comprehensive organ transplant policies, with countries, including Spain, recognized for their efficient donor management systems. The incorporation of advanced technologies and the availability of specialized transplantation services contribute to the growth of this market. The Middle East showcases a growing organ transplant market driven by increasing healthcare spending and evolving regulatory frameworks. Cultural and religious factors significantly impact consumer behavior concerning organ donation and transplants. In Africa, organ transplantation activities are hindered by infrastructure challenges and disparities in healthcare. However, some regions are making strides in establishing transplantation programs but face obstacles with funding, public awareness, and regulatory hurdles. The APAC region is experiencing rapid development in the organ transplantation market, driven by the increasing prevalence of chronic diseases, rising healthcare expenditures, and government initiatives to promote organ donation. China is rapidly growing in organ transplantation due to substantial investments in healthcare infrastructure and a growing middle class. Japan has a well-established healthcare system, with specific challenges related to an aging population and cultural resistance to organ donation. India represents a complex organ transplant market with vast disparities in access to healthcare services. There's growing demand, particularly within urban centers, with private hospitals leading transplantation services.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Organ Transplantation Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Organ Transplantation Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Organ Transplantation Market, highlighting leading vendors and their innovative profiles. These include 21st Century Medicine, AbbVie Inc., Arthrex, Inc., Artivion, Inc., Astellas Pharma Inc., Bio-Rad Laboratories, Inc., BiolifeSolutions, Inc., CHIESI Farmaceutici S.p.A. by Amryt Pharma PLC, Dr. Franz Kohler Chemie GmbH, Exactech, Inc., F. Hoffmann-La Roche Ltd, Illumina, Inc., Medtronic PLC, NHS Blood and Transplant, Novartis AG, Organ Recovery Systems, Organovo Holdings, Inc., OrganOx Limited, Pfizer Inc., Plexision, Preservation Solutions, Inc., Sanofi S.A., Stryker Corporation, Teva Pharmaceuticals Industries Ltd., Thermo Fisher Scientific Inc., TransMedics Group, Inc., Veloxis Pharmaceuticals, Inc. by Asahi Kasei Corp., and Xvivo Perfusion AB.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Organ Transplantation Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Organ Transplantation Market?
3. What are the technology trends and regulatory frameworks in the Organ Transplantation Market?
4. What is the market share of the leading vendors in the Organ Transplantation Market?
5. Which modes and strategic moves are suitable for entering the Organ Transplantation Market?